Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
January 7th, 2020 |
Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2020 |
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2020 |
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) |
National Institutes of Health |
May 25th, 2019 |
NICHD Research Education Programs (R25 Clinical Trial Optional) |
National Institutes of Health |
February 22nd, 2018 |
Collaboratory on Research Definitions for Cognitive Reserve and Resilience to Alzheimer's Disease (R24 - Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2021 |
NIDDK Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 9th, 2020 |
Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
May 8th, 2018 |
Increased Knowledge and Innovative Strategies to Reduce HIV Incidence-iKnow Projects (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2018 |
Fast-Track Development of Medications to Treat Cannabis Use Disorders (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Innovations in Mechanisms and Interventions to Address Mental Health in HIV Prevention and Care Continuum (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Targeted basic behavioral and social science and intervention development for HIV prevention and care (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2020 |
Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21 Clinical Trial Optional) |
National Institutes of Health |
March 13th, 2018 |
Innovative Research in HIV in Kidney, Urology, and Hematology (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2021 |
NIDDK Multi-Center Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) |
National Institutes of Health |
May 7th, 2018 |
NHLBI Career Transition Award for Intramural Fellows (K22) (Clinical Trials Required) |
National Institutes of Health |
September 5th, 2019 |
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
April 11th, 2019 |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) |
National Institutes of Health |
|
May 7th, 2018 |
NHLBI Career Transition Award for Intramural Fellows (K22) (No Independent Clinical Trials) |
National Institutes of Health |
November 2nd, 2020 |
NIDDK Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) |
National Institutes of Health |
September 5th, 2019 |
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
April 5th, 2019 |
Products to Support Applied Research Towards Zero Suicide Healthcare Systems (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
April 5th, 2020 |
Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
September 5th, 2019 |
T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
January 5th, 2020 |
Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R41/R42 Clinical Trial Optional) |
National Institutes of Health |
April 3rd, 2020 |
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional) |
National Institutes of Health |
April 4th, 2019 |
Wearable Alcohol Biosensors (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
April 11th, 2019 |
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2020 |
Epidemiology and Prevention in Alcohol Research (R21 - Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2020 |
Epidemiology and Prevention in Alcohol Research (R01 - Clinical Trial Optional) |
National Institutes of Health |
January 29th, 2018 |
Preventing HIV/AIDS in Vulnerable Populations in South Africa |
South Africa USAID Pretoria |
April 11th, 2019 |
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) |
National Institutes of Health |
April 5th, 2020 |
Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
September 5th, 2019 |
T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
January 5th, 2020 |
Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
April 24th, 2019 |
Evaluating the NIDA Standardized Research E-Cigarette in Risk Reduction and Related Studies (U01 Clinical Trial Optional) |
National Institutes of Health |
April 3rd, 2020 |
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
National Institutes of Health |
September 5th, 2019 |
NIDDK Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required) |
National Institutes of Health |